FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 2509189 · Received March 27, 2012

Report

Report Number
2027969-2012-00409
Event Type
Malfunction
Date Received
March 27, 2012
Date of Event
March 5, 2012
Report Date
March 27, 2012
Manufacturer
ALERE SAN DIEGO, INC
Product Code
GJS
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DATA ANALYSIS WAS NOT PERFORMED SINCE PT WAS ON LOVENOX. LOVENOX IS A CLASS OF ANTITHROMBOTIC AGENTS KNOWN AS LOW-MOLECULAR-WEIGHT HEPARINS (LMWH). PER PRODUCT USER GUIDE - LIMITATIONS, "THIS TEST SHOULD NOT BE USED FOR PTS ON HEPARIN THERAPY." FURTHER INVESTIGATION COULD NOT BE PERFORMED SINCE NO STRIP LOT INFO WAS PROVIDED BY THE CUSTOMER. THIS ISSUE WILL BE SUBJECT TO TRACKING AND TRENDING. NO CORRECTIVE ACTION REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS: DATE: (B)(6) 2012; INRATIO: 3.8; LAB: 1.8. PT'S THERAPEUTIC RANGE: 2.0-3.0 INR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC 100071 NG

Patients

Seq Age Sex Outcome Treatment
1 NI